Innova Captab Limited
Innova Captab Limited Fundamental Analysis
Innova Captab Limited (INNOVACAP.NS) shows moderate financial fundamentals with a PE ratio of 28.89, profit margin of 8.85%, and ROE of 13.81%. The company generates $15.0B in annual revenue with strong year-over-year growth of 15.48%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 62.4/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze INNOVACAP.NS's fundamental strength across five key dimensions:
Efficiency Score
WeakINNOVACAP.NS struggles to generate sufficient returns from assets.
Valuation Score
WeakINNOVACAP.NS trades at a premium to fair value.
Growth Score
ExcellentINNOVACAP.NS delivers strong and consistent growth momentum.
Financial Health Score
ExcellentINNOVACAP.NS maintains a strong and stable balance sheet.
Profitability Score
WeakINNOVACAP.NS struggles to sustain strong margins.
Key Financial Metrics
Is INNOVACAP.NS Expensive or Cheap?
P/E Ratio
INNOVACAP.NS trades at 28.89 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, INNOVACAP.NS's PEG of 4.49 indicates potential overvaluation.
Price to Book
The market values Innova Captab Limited at 3.75 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 15.57 times EBITDA. This signals the market has high growth expectations.
How Well Does INNOVACAP.NS Make Money?
Net Profit Margin
For every $100 in sales, Innova Captab Limited keeps $8.85 as profit after all expenses.
Operating Margin
Core operations generate 14.75 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $13.81 in profit for every $100 of shareholder equity.
ROA
Innova Captab Limited generates $7.82 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Innova Captab Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Innova Captab Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
INNOVACAP.NS converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
28.89
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
4.49
vs 25 benchmark
P/B Ratio
Price to book value ratio
3.75
vs 25 benchmark
P/S Ratio
Price to sales ratio
2.55
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.33
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.96
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.14
vs 25 benchmark
ROA
Return on assets percentage
0.08
vs 25 benchmark
ROCE
Return on capital employed
0.17
vs 25 benchmark
How INNOVACAP.NS Stacks Against Its Sector Peers
| Metric | INNOVACAP.NS Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 28.89 | 29.45 | Neutral |
| ROE | 13.81% | 779.00% | Weak |
| Net Margin | 8.85% | -24936.00% (disorted) | Weak |
| Debt/Equity | 0.33 | 0.26 | Weak (High Leverage) |
| Current Ratio | 1.96 | 4.65 | Neutral |
| ROA | 7.82% | -19344.00% (disorted) | Weak |
INNOVACAP.NS outperforms its industry in 0 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Innova Captab Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
179.40%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
285.75%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
73.87%
Industry Style: Defensive, Growth, Innovation
High Growth